Abstract
This study examined the prognostic predictors in 521 patients with angiographic evidence of coronary artery disease (CAD). All patients underwent exercise single-photon emission computed tomographic thallium imaging. The patients were divided into those with symptomatic ischemia defined as reversible thallium defects, S-T segment depression (or both) and angina during exercise (n= 210, group 1), and silent ischemia defined as thallium defects or ST segment depression (or both) but no angina during exercise (n = 311, group 2). During a mean follow-up of 24 ±21 months, there were 30 cardiac events (death or nonfatal myocardial infarction). The extent of CAD (2.0 ±0.8 diseased vessels in group 1 and 2.1 ±0.8 diseased vessels in group 2), the left ventricular ejection fraction, the extent of perfusion abnormality (21% ±11% in group 1 and 24% ±12% in group 2), and the peak heart rate and double product were similar in the two groups. Survival analysis showed no significant difference in the event-free survival in patients with symptomatic or silent ischemia. The 2-year event-free survival rate was 95% in group 1 and 94% in group 2 (difference not significant). The extent of perfusion abnormality and history of diabetes mellitus were the most important predictors of events. Thus the prognosis of medically treated patients with CAD is comparable in those patients with silent or symptomatic ischemia and is dependent on the extent of myocardium at risk rather than presence or absence of angina pectoris during exercise.
Similar content being viewed by others
References
Cecci AC, Dovellini EV, Marchi F, Pucci C, Santoro CM, Fazzini PF. Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1983; 1: 934–9.
Fleg JL, Gerstenblith G, Zonderman AB, et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990; 81: 428–36.
Lindsey HE, Cohn PF. “Silent” myocardial ichemia during and after exercise testing in patients with coronary artery disease. Am Heart J 1978; 95: 441–7.
Panza JA, Diodati JG, Callahan TS, Epstein SE, Quyyumi AA. Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol 1992; 20: 1092–8.
Deedwania PC, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990; 82: 1296–304.
Falcone C, De Servi S, Poma E, et al. Clinical significance of exercise-induced silent myocardial ischemia in patients with coronary artery disease. J Am Coll Cardiol 1987; 295: 9.
Assey ME, Walters GL, Hendrix GH, Carabello BA, Usher BW, Spann JF Jr. Incidence of acute myocardial infarction in patients with exercise-induced silent myocardial ischemia. Am J Cardiol 1987; 59: 497–500.
Cole JP, Ellestad MH. Significance of chest pain during treadmill exercise: correlation with coronary events. Am J Cardiol 1978; 41: 227–32.
Weiner DA, Ryan TH, McCabe CH, et al. Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol 1987; 59: 725–9
Schalet BD, Kegel JG, Heo J, Segal BL, Iskandian AS. Prognostic implications of normal exercise SPECT thallium images in patients with strongly positive exercise electrocardiograms. Am J Cardiol 1993; 72: 1201–3.
Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993; 22: 665–70.
Iskandrian AS, Johnson JH, Heo J, Wasserleben V, Cave V. Comparison of the treadmill exercise score: SPECT thallium imaging predicting prognosis in medically treated patients with coronary artery disease. J Nucl Cardiol (in press).
SAS user’s guide: statistics. 5th ed. Gary, North Carolina: SAS Institute, 1985.
Cohn PF. Silent myocardial ischemia in patients with defective anginal warning system. Am J Cardiol 1980; 45: 697–702.
Heller GV, Garber CE, Connolly MJ, et al. Plasma betaendorphin levels in silent myocardial ischemia. Am J Cardiol 1987; 59: 735–9.
Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983; 1: 940–5.
Chierchia S, Lazzari M, Freedman B, Brunelli C, Maseri A. Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol 1983; 1: 924–30.
Gasparetti CM, Burwell LR, Beller GA. Prevalence of variables associated with silent myocardial ischemia on exercise thallium-201 stress testing. J Am Coll Cardiol 1990; 16: 115–23.
Mahmarian JJ, Pratt CM, Cocanougher MK, Verani MS. Altered myocardial pefusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single photon emission computed tomography. Circulation 1990; 82: 1305–15.
Van Arnim T, Erath A. Nitrates and calcium antagonists for silent myocardial ischemia. Am J Cardiol 1988; 61: 15E-8E.
Imperi GA, Lambert CR, Coy K, Lopez I, Pepine L. Effects of titrated beta-blockers (metoprolol) on silent myocardial ischemia in ambulatory care patients with coronary artery disease. Am J Cardiol 1987; 60: 519–24.
Parmley WW, Nesto RW, Singh BN, Dearfield J, Gottlieb SD, N-CAP Study Group. Alternative of the circadian pattern of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992; 19: 1380–9.
Campbell S, Barry J, Rocco MB, et al. Features of the exercise test that reflects the activity of ischemic heart disease out of hospital. Circulation 1986; 74: 720–8.
Mody F, Nademanee K, Intrachot V, Josephson MA, Robertson HA, Singh BN. Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relationship to prognostic determinants during exercise stress testing and coronary angiography. J Am Coll Cardiol 1988; 12: 1169–76.
Gottlieb SO, Weisfeldt MC, Ouyang P, Mellits P, Gerstenblitz G. Silent ischemia as a marker of early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986; 314: 1214–9.
Rocco MB, Babel E, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988; 78: 877–84.
Bonow RO, Bacharach SL, Green MV, LaFremiere RL, Epstein SE. Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly asymptomatic and in asymptomatic patients with angiographically documented coronary artery disease. Am J Cardiol 1987; 60: 778–83.
Weiner DA, Ryan TJ, McCabe CH, et al. Comparison of coronary artery bypass surgery and medical therapy in patients with exercise-induced silent myocardial ischemia: a report from the Coronary Artery Surgery Study (CASS) Registry. J Am Coll Cardiol 1988; 12: 595–9.
Mark DB, Hlatky MA, Califf RM, et al. Painless exercise S-T deviation on the treadmill: long term prognosis. J Am Coll Cardiol 1989; 14: 885–92.
Hendel RD, Layden JJ, Leppo JA. Prognostic value of dipyridamole-thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990; 15: 109–16.
Kamal AM, Fattah AA, Pancholy S, et al. Prognostic value of adenosine SPECT thallium imaging in medically treated patients with angiographic evidence of coronary artery disease.J Nucl Cardiol (in press).
Author information
Authors and Affiliations
Additional information
Presented in part at the Sixty-sixth Annual Scientific Sessions of the American Heart Association, Atlanta, Ga., November 1993.
Rights and permissions
About this article
Cite this article
Pancholy, S.B., Schalet, B., Kuhlmeier, V. et al. Prognostic significance of silent ischemia. J. Nucl. Cardiol. 1, 434–440 (1994). https://doi.org/10.1007/BF02961597
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02961597